1. ATP7B rs9535826 is associated with gastrointestinal toxicity of platinum-based chemotherapy in nonsmall cell lung cancer patients
   Yue-Qin Li et al, 2018, Journal of Cancer Research and Therapeutics CrossRef
2. Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
   Wei Gao et al, 2021, Molecular Oncology CrossRef
3. TAp73 regulates ATP7A: possible implications for ageing-related diseases
   Piervito Lopriore et al, 2018, Aging CrossRef
4. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
   Jia Yee Lee et al, 2024, Biomedicine & Pharmacotherapy CrossRef
5. Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives
   Benjamin N. Forgie et al, 2022, International Journal of Molecular Sciences CrossRef
6. WSG, a Glucose-Rich Polysaccharide from Ganoderma lucidum, Combined with Cisplatin Potentiates Inhibition of Lung Cancer In Vitro and In Vivo
   Wei-Lun Qiu et al, 2021, Polymers CrossRef
7. MicroRNA-495: a therapeutic and diagnostic tumor marker
   Amirhosein Maharati et al, 2023, Journal of Molecular Histology CrossRef
8. Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy
   Yue‐Qin Li et al, 2018, IUBMB Life CrossRef
9. Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells
   R Schreiber et al, 2016, Cancer Gene Therapy CrossRef
10. Pharmacogenomics for the efficacy of platinum-based chemotherapy: Old drugs, new integrated perspective
    Chen-Xue Mao et al, 2020, Biomedicine & Pharmacotherapy CrossRef
11. Cisplatin resistance and opportunities for precision medicine
    Lauren Amable, 2016, Pharmacological Research CrossRef
12. Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells
    Ting-Ting Gong et al, 2020, Experimental Cell Research CrossRef
13. Cytotoxic effects of pyrrolidine dithiocarbamate in small-cell lung cancer cells, alone and in combination with cisplatin
    SHINICHI TAHATA et al, 2014, International Journal of Oncology CrossRef
14. A Chinese herbal Formula, Chang-Wei-Qin, Synergistically Enhances Antitumor Effect of Oxaliplatin
    Yong Zhang et al, 2015, Pathology & Oncology Research CrossRef
15. miR‐495 Enhances the Sensitivity of Non‐Small Cell Lung Cancer Cells to Platinum by Modulation of Copper‐Transporting P‐type Adenosine Triphosphatase A (ATP7A)
    Liqiang Song et al, 2014, Journal of Cellular Biochemistry CrossRef
16. Interaction of Copper Trafficking Proteins with the Platinum Anticancer Drug Kiteplatin
    Alessandra Barbanente et al, 2022, ChemMedChem CrossRef
17. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
    Maria Konoshenko et al, 2022, International Journal of Molecular Sciences CrossRef
18. MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
    Irina Fadejeva et al, 2017, Oncotarget CrossRef
19. Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma
    Jialu Chen et al, 2022, Frontiers in Oncology CrossRef
20. Toosendanin mediates cisplatin sensitization through targeting Annexin A4/ATP7A in non-small cell lung cancer cells
    Mao Dong Zheng et al, 2018, Journal of Natural Medicines CrossRef
21. Copper metabolism as a unique vulnerability in cancer
    Vinit C. Shanbhag et al, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
22. Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
    Hong Peng et al, 2023, Medicine CrossRef